Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Long

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Dermatology|August 30, 2024
Selling sunbedsAmy Long, Alison Long, Karen Eustace
Clinical and Experimental Dermatology|August 23, 2023
Patient education: a colourful read?Amy Long, Alison Long, Cliona Feighery
Clinical and Experimental Dermatology|October 28, 2024
Comment on "A not-so healthy glow: a qualitative analysis of sunbed content and viewer engagement on social media"Amy Long, Alison Long, Joseph Siby, et al.
Thrombosis and Haemostasis|November 6, 2009
M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromesTakashi Kei Kishimoto, Yi Wei Qi, Alison Long, et al.
Endocrine|April 13, 2018
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophyRebecca J Brown, Elif A Oral, Elaine Cochran, et al.
Endocrine|February 27, 2019
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophyElif A Oral, Phillip Gorden, Elaine Cochran, et al.
Microsystems & Nanoengineering|September 27, 2021
3D microfluidic gradient generator for combination antimicrobial susceptibility testingEric Sweet, Brenda Yang, Joshua Chen, et al.
Blood Advances|November 8, 2019
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia BAnnette Von Drygalski, Adam Giermasz, Giancarlo Castaman, et al.
The New England Journal of Medicine|July 20, 2022
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia BPratima Chowdary, Susan Shapiro, Mike Makris, et al.
Plos One|June 24, 2011
M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasisHe Zhou, Sucharita Roy, Edward Cochran, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Dermatology|August 30, 2024
Selling sunbedsAmy Long, Alison Long, Karen Eustace
Clinical and Experimental Dermatology|August 23, 2023
Patient education: a colourful read?Amy Long, Alison Long, Cliona Feighery
Clinical and Experimental Dermatology|October 28, 2024
Comment on "A not-so healthy glow: a qualitative analysis of sunbed content and viewer engagement on social media"Amy Long, Alison Long, Joseph Siby, et al.
Thrombosis and Haemostasis|November 6, 2009
M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromesTakashi Kei Kishimoto, Yi Wei Qi, Alison Long, et al.
Endocrine|April 13, 2018
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophyRebecca J Brown, Elif A Oral, Elaine Cochran, et al.
Endocrine|February 27, 2019
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophyElif A Oral, Phillip Gorden, Elaine Cochran, et al.
Microsystems & Nanoengineering|September 27, 2021
3D microfluidic gradient generator for combination antimicrobial susceptibility testingEric Sweet, Brenda Yang, Joshua Chen, et al.
Blood Advances|November 8, 2019
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia BAnnette Von Drygalski, Adam Giermasz, Giancarlo Castaman, et al.
The New England Journal of Medicine|July 20, 2022
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia BPratima Chowdary, Susan Shapiro, Mike Makris, et al.
Plos One|June 24, 2011
M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasisHe Zhou, Sucharita Roy, Edward Cochran, et al.
Pageof 1